Children's Cold and Allergy Medicines Recalled
Author: Ian C. Langtree - View Credentials
Published: 1 May 2010
Table of Contents:
Synopsis - Overview - Related Content
Synopsis
Recall has been issued for more than 40 over-the-counter drugs for children including Tylenol and Motrin.
Overview
A voluntary recall has been issued for more than 40 over-the-counter drugs for children, including Tylenol and Motrin, because they don't meet quality standards."This recall is not being undertaken on the basis of adverse medical events," McNeil Consumer Healthcare said in a statement Friday. "However, as a precautionary measure, parents and caregivers should not administer these products to their children."
"Some products in the recall may have a higher concentration of active ingredient than specified while others may have inactive ingredients that don't meet testing requirements, the company said.
The company said it issued the recall after consulting with the Food and Drug Administration. The affected brands include: Tylenol Infants' Drops, Children's Tylenol Suspensions, Children's Tylenol Plus Suspensions, Motrin Infant Drops, Children's Motrin Suspensions, Children's Zyrtec Liquids in Bottles and Children's Benadryl Allergy Liquids in Bottles.
The drugs were made in the United States and distributed to Canada, the Dominican Republic, Dubai, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago and Kuwait.
Author Credentials: Ian C. Langtree is a writer, editor, and the founder and Editor-in-Chief of Disabled World, which he established in 2004 as one of the longest-running independent resources for disability news and information. Over more than two decades, he has written and edited thousands of articles on disability rights, health, accessibility, and assistive technology. Drawing on a global perspective shaped by extensive travel and lived experience, Ian is a committed advocate of the Social Model of Disability, the framework developed by disabled activists in the 1970s that focuses on removing societal barriers rather than on individual impairments. His writing is grounded in that framework and in a lasting commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.